Healthcare & Life Sciences
Tobira Therapeutics
United Stateswww.tobiratherapeutics.com
acquiredacquired
acquired
Stage
2007
Founded
2
Investors
About
Tobira Therapeutics was a clinical-stage biopharmaceutical company focused on developing novel treatments for non-alcoholic steatohepatitis (NASH) and other liver diseases. The company was acquired by Allergan in 2016.
Explore Tobira Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.